The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation
- PMID:9210483
- DOI: 10.1111/j.1432-1033.1997.t01-1-00193.x
The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation
Abstract
The lantibiotic mersacidin has been previously reported to interfere with bacterial peptidoglycan biosynthesis, [Brötz, H., Bierbaum, G., Markus, A., Molitor, E. & Sahl, H.-G. (1995) Antimicrob. Agents Chemother. 39, 714-719]. Here, we focus on the target reaction and describe a mersacidin-induced accumulation of UDP-N-acetylmuramoyl-pentapeptide, indicating that inhibition of peptidoglycan synthesis occurs after the formation of cytoplasmic precursors. In vitro studies involving a wall-membrane particulate fraction of Bacillus megaterium KM demonstrated that mersacidin did not prevent the synthesis of lipid II [undecaprenyl-diphosphoryl-N-acetylmuramoyl-(pentapeptide)-N-ac ety lglucosamine] but specifically the subsequent conversion of this intermediate into polymeric nascent glycan strands by transglycosylation. Comparison with other inhibitors of transglycosylation shows that the effective concentration of mersacidin in vitro is in the range of that of the glycopeptide antibiotic vancomycin but 2-3 orders of magnitude higher than that of the competitive enzyme inhibitor moenomycin. The analogy to the glycopeptides may hint at an interaction of mersacidin with the peptidoglycan precursor rather than with the enzyme. Unlike vancomycin however, mersacidin inhibits peptidoglycan formation from UDP-N-acetylmuramoyl-tripeptide and is active against Enterococcus faecium expressing the vanA resistance gene cluster. This indicates that the molecular target site of mersacidin differs from that of vancomycin and that no cross-resistance exists between the two antibiotics.
Similar articles
- Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?Brötz H, Bierbaum G, Markus A, Molitor E, Sahl HG.Brötz H, et al.Antimicrob Agents Chemother. 1995 Mar;39(3):714-9. doi: 10.1128/AAC.39.3.714.Antimicrob Agents Chemother. 1995.PMID:7793878Free PMC article.
- The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting lipid II.Brötz H, Bierbaum G, Leopold K, Reynolds PE, Sahl HG.Brötz H, et al.Antimicrob Agents Chemother. 1998 Jan;42(1):154-60. doi: 10.1128/AAC.42.1.154.Antimicrob Agents Chemother. 1998.PMID:9449277Free PMC article.
- Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.Allen NE, Hobbs JN Jr, Nicas TI.Allen NE, et al.Antimicrob Agents Chemother. 1996 Oct;40(10):2356-62. doi: 10.1128/AAC.40.10.2356.Antimicrob Agents Chemother. 1996.PMID:8891144Free PMC article.
- Antimicrobial mechanism of lantibiotics.Islam MR, Nagao J, Zendo T, Sonomoto K.Islam MR, et al.Biochem Soc Trans. 2012 Dec 1;40(6):1528-33. doi: 10.1042/BST20120190.Biochem Soc Trans. 2012.PMID:23176511Review.
- Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.Grein F, Schneider T, Sahl HG.Grein F, et al.J Mol Biol. 2019 Aug 23;431(18):3520-3530. doi: 10.1016/j.jmb.2019.05.014. Epub 2019 May 14.J Mol Biol. 2019.PMID:31100388Review.
Cited by
- Synthesis of the AviMeCys-containing D-ring of mersacidin.Carrillo AK, VanNieuwenhze MS.Carrillo AK, et al.Org Lett. 2012 Feb 17;14(4):1034-7. doi: 10.1021/ol2034806. Epub 2012 Feb 1.Org Lett. 2012.PMID:22296295Free PMC article.
- Structure-activity exploration of a small-molecule Lipid II inhibitor.Fletcher S, Yu W, Huang J, Kwasny SM, Chauhan J, Opperman TJ, MacKerell AD Jr, de Leeuw E.Fletcher S, et al.Drug Des Devel Ther. 2015 Apr 24;9:2383-94. doi: 10.2147/DDDT.S79504. eCollection 2015.Drug Des Devel Ther. 2015.PMID:25987836Free PMC article.
- Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster.Altena K, Guder A, Cramer C, Bierbaum G.Altena K, et al.Appl Environ Microbiol. 2000 Jun;66(6):2565-71. doi: 10.1128/AEM.66.6.2565-2571.2000.Appl Environ Microbiol. 2000.PMID:10831439Free PMC article.
- Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms.Vanzolini T, Bruschi M, Rinaldi AC, Magnani M, Fraternale A.Vanzolini T, et al.Int J Mol Sci. 2022 Jan 4;23(1):545. doi: 10.3390/ijms23010545.Int J Mol Sci. 2022.PMID:35008974Free PMC article.Review.
- Bibacillin 1: A two-component lantibiotic fromBacillus thuringiensis.Moreira R, Yang Y, Luo Y, Gilmore MS, van der Donk W.Moreira R, et al.bioRxiv [Preprint]. 2024 Aug 14:2024.08.13.607848. doi: 10.1101/2024.08.13.607848.bioRxiv. 2024.Update in:RSC Chem Biol. 2024 Sep 4. doi: 10.1039/d4cb00192c.PMID:39185197Free PMC article.Updated.Preprint.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical